Technically Speaking: Preventing Fainting and Associated Injuries After Vaccination
Published on
Vaccine Update for Healthcare ProvidersPublished on
Vaccine Update for Healthcare ProvidersImmunization providers should be aware of the potential for syncope, or fainting, associated with vaccination, particularly among adolescents. Providers should take appropriate measures to prevent syncope and to readily respond to the patient who feels faint. Here are some things your practice can do to prepare:
The May 8, 2008, issue of the Morbidity and Mortality Weekly Report included an article titled Syncope After Vaccination — United States, January 2005-July 2007 in which the Centers for Disease Control and Prevention (CDC) reported that since 2005, the Vaccine Adverse Events Reporting System had received a greater number of reports of syncope compared with the number reported in 2002–2004. The increase coincided with the licensure of three vaccines for adolescents — HPV, MCV, and Tdap. The increase in syncopal episodes had occurred primarily in females age 11-18 years. Though rare, serious injuries have occurred, including one fatality in a 15-year-old boy who had an intracranial hemorrhage caused by head trauma from a fall. Among all age groups, 80 percent of reported syncopal episodes occurred within 15 minutes of vaccine administration.
The CDC’s General Recommendations on Immunization: A Report of the Advisory Committee on Immunization Practices(PDF) states, “Vaccine providers, particularly when vaccinating adolescents, should consider observing patients (with patients seated or lying down) for 15 minutes after vaccination to decrease the risk for injury should they faint. If syncope develops, patients should be observed until the symptoms resolve."
The Immunization Action Coalition has developed two educational pieces on the medical management of adverse reactions (including syncope) to vaccination:
Categories: Technically Speaking, Vaccine Update April 2012